MicroRNAs as Modulators of the Immune Response in T-Cell Acute Lymphoblastic Leukemia

被引:7
|
作者
Del Gaizo, Martina [1 ]
Sergio, Ilaria [2 ]
Lazzari, Sara [1 ]
Cialfi, Samantha [1 ]
Pelullo, Maria [3 ]
Screpanti, Isabella [1 ]
Felli, Maria Pia [2 ]
机构
[1] Sapienza Univ Rome, Dept Mol Med, I-00161 Rome, Italy
[2] Sapienza Univ Rome, Dept Expt Med, I-00161 Rome, Italy
[3] Ist Italiano Tecnol, Ctr Life Nano Sci Sapienza, I-00161 Rome, Italy
关键词
microRNA; Notch; Natural Killer cells; T and regulatory T cells; MDSC; Acute lymphoblastic leukaemia; SUPPRESSOR-CELLS; TUMOR-SUPPRESSOR; MOLECULAR-MECHANISMS; NK CELLS; NOTCH; EXPRESSION; ACTIVATION; INFLAMMATION; REVEALS; EVASION;
D O I
10.3390/ijms23020829
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Acute lymphoblastic leukaemia (ALL) is an aggressive haematological tumour driven by the malignant transformation and expansion of B-cell (B-ALL) or T-cell (T-ALL) progenitors. The evolution of T-ALL pathogenesis encompasses different master developmental pathways, including the main role played by Notch in cell fate choices during tissue differentiation. Recently, a growing body of evidence has highlighted epigenetic changes, particularly the altered expression of microRNAs (miRNAs), as a critical molecular mechanism to sustain T-ALL. The immune response is emerging as key factor in the complex multistep process of cancer but the role of miRNAs in anti-leukaemia response remains elusive. In this review we analyse the available literature on miRNAs as tuners of the immune response in T-ALL, focusing on their role in Natural Killer, T, T-regulatory and Myeloid-derived suppressor cells. A better understanding of this molecular crosstalk may provide the basis for the development of potential immunotherapeutic strategies in the leukemia field.
引用
收藏
页数:19
相关论文
共 50 条
  • [21] T-CELL ACUTE LYMPHOBLASTIC-LEUKEMIA IN ADULTS
    MACKINTOSH, W
    RICHARDS, JDM
    JACOBS, P
    SOUTH AFRICAN MEDICAL JOURNAL, 1985, 67 (12): : 450 - 452
  • [22] Nelarabine (Arranon) for T-cell acute lymphoblastic leukemia
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2006, 48 (1228): : 14 - 15
  • [23] Beating the Clock in T-cell Acute Lymphoblastic Leukemia
    Carroll, William L.
    Aifantis, Iannis
    Raetz, Elizabeth
    CLINICAL CANCER RESEARCH, 2017, 23 (04) : 873 - 875
  • [24] Therapy of acute lymphoblastic leukemia of T-cell phenotype
    Look, KA
    Amylon, MD
    INTERNATIONAL JOURNAL OF PEDIATRIC HEMATOLOGY/ONCOLOGY, 1998, 5 (2-4): : 73 - 80
  • [25] MOLECULAR GENETICS OF T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA
    Cools, Jan
    EXPERIMENTAL HEMATOLOGY, 2013, 41 (08) : S6 - S6
  • [26] The epigenetic landscape of T-cell acute lymphoblastic leukemia
    Van der Meulen, Joni
    Van Roy, Nadine
    Van Vlierberghe, Pieter
    Speleman, Frank
    INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2014, 53 : 547 - 557
  • [27] ABLI Rearrangements in T-Cell Acute Lymphoblastic Leukemia
    Hagemeijer, Anne
    Graux, Carlos
    GENES CHROMOSOMES & CANCER, 2010, 49 (04): : 299 - 308
  • [28] T-cell adoptive immunotherapy for acute lymphoblastic leukemia
    Fry, Terry J.
    Mackall, Crystal L.
    HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2013, : 348 - 353
  • [29] New Approaches to T-Cell Acute Lymphoblastic Leukemia
    Teachey, David T.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2022, 20 (05) : 295 - 298
  • [30] T-cell acute lymphoblastic leukemia/orbital lymphoblastic lymphoma in children
    Abdelouahed, K
    Laghmari, M
    Tachfouti, S
    Cherkaoui, W
    Khorassani, M
    M'Seffer, FA
    Mohcine, Z
    JOURNAL FRANCAIS D OPHTALMOLOGIE, 2005, 28 (02): : 197 - 200